ESC Premium Access

Is rivaroxaban associated with shorter hospital stays and reduced costs vs. parenteral bridging to warfarin among pulmonary embolism patients?

Congress Presentation

About the speaker

Doctor Erin Weeda

University of Connecticut, Storrs (United States of America)
0 follower

4 more presentations in this session

State of the art in the management of pulmonary embolism.

Speaker: Professor C. Becattini (Perugia, IT)

Thumbnail

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation

Speaker: Doctor E. Klok (Leiden, NL)

Thumbnail

National trends in inferior vena cava filter placement in the United States from 2005 to 2013

Speaker: Professor D. Brown (Los Angeles, US)

Thumbnail

Future direction for research in pulmonary embolism.

Speaker: Professor H. Buller (Amsterdam, NL)

Thumbnail

Access the full session

Optimizing the treatment of pulmonary embolism

Speakers: Doctor E. Weeda, Professor C. Becattini, Doctor E. Klok, Professor D. Brown, Professor H. Buller
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb